Income StatementBalance SheetCash FlowSegments
ALM

Alamar Biosciences, Inc. Common Stock Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Alamar Biosciences, Inc. Common Stock holds $186.5M in total assets. Shareholders' equity is -$178.1M against $30.6M in total debt. Cash and equivalents total $64.6M. The current ratio is 5.88 and debt-to-equity is -0.172. Based on the Q1 2026 filing.

Total Assets$186.5MTotal Stockholders Equity-$178.1MCash And Equivalents$64.6MTotal Current Assets$141.5MTotal Current Liabilities$24.0M
Latest FilingQ1 2026
Report Date2026-05-08

Current Liabilities

MetricQ4 '25Q1 '26
Accounts payable$5.9M$5.6M
Operating lease liabilities, current$2.1M$1.6M
Total current liabilities$23.7M$24.0M

Current Assets

MetricQ4 '25Q1 '26
Accounts receivable, net$12.8M$19.5M
Cash and cash equivalents$30.0M$64.6M
Inventories$38.5M$39.9M
Prepaid expenses and other current assets$13.5M$17.4M
Restricted cash$4.9M$4.9M
Total current assets$94.7M$141.5M

Equity

MetricQ4 '25Q1 '26
Additional paid-in capital$9.9M$12.1M
Accumulated other comprehensive income (loss)-$72.0K-$80.0K
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$1.0K$1.0K
Retained earnings-$168.8M-$190.1M
Total liabilities and stockholders' equity$140.0M$186.5M
Total stockholders' equity-$159.0M-$178.1M

Non-Current Assets

MetricQ4 '25Q1 '26
Capitalized software licenses$2.0M$1.8M
Operating lease right-of-use assets$26.1M$25.7M
Other non-current assets$1.8M$2.1M
Property and equipment, net$10.5M$10.5M
Total assets$140.0M$186.5M

Non-Current Liabilities

MetricQ4 '25Q1 '26
Accrued expenses and other liabilities$15.8M$16.8M
Operating lease liabilities, non-current$29.6M$29.0M
Other non-current liabilities$599.0K$1.2M
Total liabilities$64.0M$129.5M

Other

MetricQ4 '25Q1 '26
Convertible Debt—$65.1M
Term Debt$9.8M$9.9M
Warrant Liabilities$247.0K$331.0K